Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Friedlander

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Infection and Immunity|July 23, 2003
Genome-based bioinformatic selection of chromosomal Bacillus anthracis putative vaccine candidates coupled with proteomic identification of surface-associated antigensN Ariel, A Zvi, K S Makarova, et al.
Vaccine|July 31, 1998
Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccineD G Heath, G W Anderson, J M Mauro, et al.
Infection and Immunity|March 20, 1999
Immune response to Yersinia outer proteins and other Yersinia pestis antigens after experimental plague infection in miceG E Benner, G P Andrews, W R Byrne, et al.
The American Journal of Tropical Medicine and Hygiene|April 1, 1997
Protection of mice from fatal bubonic and pneumonic plague by passive immunization with monoclonal antibodies against the F1 protein of Yersinia pestisG W Anderson, P L Worsham, C R Bolt, et al.
Infection and Immunity|November 1, 1996
Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestisG W Anderson, S E Leary, E D Williamson, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 1, 1995
Pathology of experimental inhalation anthrax in the rhesus monkeyD L Fritz, N K Jaax, W B Lawrence, et al.
Vaccine|August 10, 2000
Anthrax vaccine: increasing intervals between the first two doses enhances antibody response in humansP R Pittman, J A Mangiafico, C A Rossi, et al.
Vaccine|April 20, 2001
Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical originP F Fellows, M K Linscott, B E Ivins, et al.
Vaccine|September 6, 2001
In vitro correlate of immunity in a rabbit model of inhalational anthraxM L Pitt, S F Little, B E Ivins, et al.
Microbiology (Reading, England)|October 17, 2009
Processing, assembly and localization of a Bacillus anthracis spore proteinK L Moody, A Driks, G L Rother, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Infection and Immunity|July 23, 2003
Genome-based bioinformatic selection of chromosomal Bacillus anthracis putative vaccine candidates coupled with proteomic identification of surface-associated antigensN Ariel, A Zvi, K S Makarova, et al.
Vaccine|July 31, 1998
Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccineD G Heath, G W Anderson, J M Mauro, et al.
Infection and Immunity|March 20, 1999
Immune response to Yersinia outer proteins and other Yersinia pestis antigens after experimental plague infection in miceG E Benner, G P Andrews, W R Byrne, et al.
The American Journal of Tropical Medicine and Hygiene|April 1, 1997
Protection of mice from fatal bubonic and pneumonic plague by passive immunization with monoclonal antibodies against the F1 protein of Yersinia pestisG W Anderson, P L Worsham, C R Bolt, et al.
Infection and Immunity|November 1, 1996
Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestisG W Anderson, S E Leary, E D Williamson, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 1, 1995
Pathology of experimental inhalation anthrax in the rhesus monkeyD L Fritz, N K Jaax, W B Lawrence, et al.
Vaccine|August 10, 2000
Anthrax vaccine: increasing intervals between the first two doses enhances antibody response in humansP R Pittman, J A Mangiafico, C A Rossi, et al.
Vaccine|April 20, 2001
Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical originP F Fellows, M K Linscott, B E Ivins, et al.
Vaccine|September 6, 2001
In vitro correlate of immunity in a rabbit model of inhalational anthraxM L Pitt, S F Little, B E Ivins, et al.
Microbiology (Reading, England)|October 17, 2009
Processing, assembly and localization of a Bacillus anthracis spore proteinK L Moody, A Driks, G L Rother, et al.
Pageof 7